|
2025 Journal Article A rapid molecular detection tool for toxigenic M1UK Streptococcus pyogenesBrouwer, Stephan, Das, Swairindhree, Hayes, Andrew J., Bertolla, Olivia M., Davies, Mark R., Walker, Mark J., Whiley, David M., Irwin, Adam D. and Tickner, Jacob A. (2025). A rapid molecular detection tool for toxigenic M1UK Streptococcus pyogenes. The Journal of Infectious Diseases, 231 (2), e375-e384. doi: 10.1093/infdis/jiae437 |
|
2025 Journal Article A perplexing diagnosis: role of real-time PCR for diagnosis of Haycocknema perplexumDavidson, Natalie, Lowry, Kym, Parmar, Bijendrasinh Vikramsinh, Robertson, Thomas, Gupta, Rita, Harris, Patrick and Whiley, David (2025). A perplexing diagnosis: role of real-time PCR for diagnosis of Haycocknema perplexum. Pathology, 57, S92. doi: 10.1016/j.pathol.2024.12.378 |
|
2024 Journal Article A novel murine model mimicking male genital Neisseria species infection using Neisseria musculiBryan, Emily R., McRae, Julia, Kumar, Vishnu, Trim, Logan K, Maidment, Toby I, Tickner, Jacob A D, Sweeney, Emma L, William, Elizabeth D, Whiley, David M and Beagley, Kenneth W (2024). A novel murine model mimicking male genital Neisseria species infection using Neisseria musculi. Biology of Reproduction, 111 (3), 613-624. doi: 10.1093/biolre/ioae100 |
|
2024 Journal Article Emergence of an extensively drug-resistant Neisseria gonorrhoeae clonevan Hal, Sebastiaan J., Sherry, Norelle, Coombs, Geoff, Mowlaboccus, Shakeel, Whiley, David M. and Lahra, Monica M. (2024). Emergence of an extensively drug-resistant Neisseria gonorrhoeae clone. The Lancet Infectious Diseases, 24 (9), e547-e548. doi: 10.1016/s1473-3099(24)00486-9 |
|
2024 Journal Article Clinical effectiveness and analytical quality of a national point-of-care testing network for sexually transmitted infections integrated into rural and remote primary care clinics in Australia, 2016–2022: an observational program evaluationCauser, Louise M., Ward, James (TTANGO2 Collaboration), Smith, Kirsty, Saha, Amit, Andrewartha, Kelly, Wand, Handan, Hengel, Belinda, Badman, Steven G., Tangey, Annie, Matthews, Susan, Mak, Donna, Gunathilake, Manoji, Moore, Elizabeth, Speers, David, Persing, David, Anderson, David, Whiley, David (TTANGO2 Collaboration), Maher, Lisa, Regan, David, Donovan, Basil, Fairley, Christopher, Kaldor, John, Shephard, Mark, Guy, Rebecca and TTANGO2 Collaboration (2024). Clinical effectiveness and analytical quality of a national point-of-care testing network for sexually transmitted infections integrated into rural and remote primary care clinics in Australia, 2016–2022: an observational program evaluation. The Lancet Regional Health - Western Pacific, 48 101110, 1-12. doi: 10.1016/j.lanwpc.2024.101110 |
|
2024 Journal Article Ceftriaxone resistance in Neisseria gonorrhoeae associated with the penA-60.001 allele in Hanoi, Viet NamAdamson, Paul C., Hieu, Vu N., Nhung, Pham H., Whiley, D. M. and Chau, T. M. (2024). Ceftriaxone resistance in Neisseria gonorrhoeae associated with the penA-60.001 allele in Hanoi, Viet Nam. The Lancet Infectious Diseases, 24 (6), e351-e352. doi: 10.1016/s1473-3099(24)00230-5 |
|
2024 Journal Article Sustained transmission over two decades of a previously unrecognised MPT64 negative Mycobacterium tuberculosis strain in Queensland, Australia: a whole genome sequencing studyBainomugisa, Arnold, Pandey, Sushil, O'Connor, Bridget, Syrmis, Melanie, Whiley, David, Sintchenko, Vitali, Coin, Lachlan J.M., Marais, Ben J. and Coulter, Christopher (2024). Sustained transmission over two decades of a previously unrecognised MPT64 negative Mycobacterium tuberculosis strain in Queensland, Australia: a whole genome sequencing study. The Lancet Regional Health - Western Pacific, 47 101105, 1-12. doi: 10.1016/j.lanwpc.2024.101105 |
|
2024 Journal Article The AMR Hub: a public–private partnership to overcome barriers to commercialisation and deliver antimicrobial stewardship innovationsBonello, Michelle, Applegate, Tanya L., Badman, Steve, Bradshaw, Catriona S., Broom, Alex, Field, Paul, Hocking, Jane S., Huston, Wilhelmina M., Kong, Fabian, Murray, Gerald L., Mokany, Elisa, Pasricha, Shivani, Todd, Alison V., Whiley, David M., Wiseman, Virginia and Guy, Rebecca (2024). The AMR Hub: a public–private partnership to overcome barriers to commercialisation and deliver antimicrobial stewardship innovations. Microbiology Australia, 45 (2), 48-53. doi: 10.1071/MA24017 |
|
2024 Journal Article Comprehensive observational study evaluating the enduring effectiveness of 4CMenB, the meningococcal B vaccine against gonococcal infections in the Northern Territory and South Australia, Australia: study protocolMarshall, Helen, Ward, James, Wang, Bing, Andraweera, Prabha, McMillan, Mark, Flood, Louise, Bell, Charlotte, Sisnowski, Jana, Krause, Vicki, Webby, Rosalind, Childs, Emma, Gunathilake, Manoji, Egoroff, Natasha, Leong, Lex, Lawrence, Andrew, Baird, Rob, Freeman, Kevin, Menouhos, Dimitrios, Whiley, David M, Karnon, Jonathan, van Hal, Sebastian and Lahra, Monica M (2024). Comprehensive observational study evaluating the enduring effectiveness of 4CMenB, the meningococcal B vaccine against gonococcal infections in the Northern Territory and South Australia, Australia: study protocol. BMJ Open, 14 (5) e079144, 1-8. doi: 10.1136/bmjopen-2023-079144 |
|
2024 Journal Article Correction: Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsisChai, Ming G., Tu, Quyen, Cotta, Menino O., Bauer, Michelle J., Balch, Ross, Okafor, Charles, Comans, Tracy, Kruger, Peter, Meyer, Jason, Shekar, Kiran, Brady, Kara, Fourie, Cheryl, Sharp, Natalie, Vlad, Luminita, Whiley, David, Ungerer, Jacobus P. J., Mcwhinney, Brett C., Farkas, Andras, Paterson, David L., Clark, Julia E., Hajkowicz, Krispin, Raman, Sainath, Bialasiewicz, Seweryn, Lipman, Jeffrey, Forde, Brian M., Harris, Patrick N. A., Schlapbach, Luregn J., Coin, Lachlan, Roberts, Jason A. and Irwin, Adam D. (2024). Correction: Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis. Intensive Care Medicine, 50 (5), 810-810. doi: 10.1007/s00134-024-07393-9 |
|
2024 Journal Article Multicentre double-blind randomised placebo-controlled trial evaluating the efficacy of the meningococcal B vaccine, 4CMenB (Bexsero), against Neisseria gonorrhoeae infection in men who have sex with men: the GoGoVax study protocolSeib, Kate L., Donovan, Basil, Thng, Caroline, Lewis, David A., McNulty, Anna, Fairley, Christopher K., Yeung, Barbara, Jin, Fengyi, Fraser, Doug, Bavinton, Benjamin R., Law, Matthew, Chen, Marcus Y., Chow, Eric P. F., Whiley, David M., Mackie, Brent, Jennings, Michael P., Jennison, Amy V., Lahra, Monica M. and Grulich, Andrew E. (2024). Multicentre double-blind randomised placebo-controlled trial evaluating the efficacy of the meningococcal B vaccine, 4CMenB (Bexsero), against Neisseria gonorrhoeae infection in men who have sex with men: the GoGoVax study protocol. BMJ Open, 14 (4) e081675, 1-9. doi: 10.1136/bmjopen-2023-081675 |
|
2024 Journal Article Response to the ASHM 2023 statement on the use of doxy-PEP in Australia: considerations and recommendationsBell, Sara F. E., Sweeney, Emma L., Kong, Fabian Y. S., Whiley, David M., Bradshaw, Catriona S. and Tickner, Jacob A. (2024). Response to the ASHM 2023 statement on the use of doxy-PEP in Australia: considerations and recommendations. Medical Journal of Australia, 220 (7), 356-360. doi: 10.5694/mja2.52255 |
|
2024 Journal Article Point-of-care testing and treatment of sexually transmitted and genital infections to improve birth outcomes in high-burden, low-resource settings (WANTAIM): a pragmatic cluster randomised crossover trial in Papua New GuineaRiddell, Michaela A., Vallely, Lisa M., Mengi, Alice, Badman, Steven G., Low, Nicola, Wand, Handan, Bolnga, John W., Babona, Delly, Mola, Glen D. L., Wiseman, Virginia, Kelly-Hanku, Angela, Homer, Caroline S. E., Morgan, Christopher, Luchters, Stanley, Whiley, David M., Robinson, Leanne J., Au, Lucy, Pukai-Gani, Irene, Laman, Moses, Kariwiga, Grace, Toliman, Pamela J., Batura, Neha, Tabrizi, Sepehr N., Rogerson, Stephen J., Garland, Suzanne M., Guy, Rebecca J., Peeling, Rosanna W., Pomat, William S., Kaldor, John M. and Vallely, Andrew J. B. (2024). Point-of-care testing and treatment of sexually transmitted and genital infections to improve birth outcomes in high-burden, low-resource settings (WANTAIM): a pragmatic cluster randomised crossover trial in Papua New Guinea. Lancet Global Health, 12 (4), e641-e651. doi: 10.1016/S2214-109X(24)00004-4 |
|
2024 Journal Article Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsisChai, Gene G., Tu, Quyen, Cotta, Menino O., Bauer, Michelle J., Balch, Ross, Okafor, Charles, Comans, Tracy, Kruger, Peter, Meyer, Jason, Shekar, Kiran, Brady, Kara, Fourie, Cheryl, Sharp, Natalie, Vlad, Luminita, Whiley, David, Ungerer, Jacobus P. J., McWhinney, Brett C., Farkas, Andras, Paterson, David L., Clark, Julia E., Hajkowicz, Krispin, Raman, Sainath, Bialasiewicz, Seweryn, Lipman, Jeffrey, Forde, Brian M., Harris, Patrick N. A., Schlapbach, Luregn J., Coin, Lachlan, Roberts, Jason A. and Irwin, Adam D. (2024). Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis. Intensive Care Medicine, 50 (4), 1-9. doi: 10.1007/s00134-024-07353-3 |
|
2024 Journal Article High prevalence of ceftriaxone-resistant and XDR Neisseria gonorrhoeae in several cities of Cambodia, 2022–23: WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP)Ouk, V, Heng, L Say, Virak, M, Deng, S, Lahra, M M, Frankson, R, Kreisel, K, McDonald, R, Escher, M, Unemo, M, Wi, T, Maatouk, I, Penh, Phnom, Fensham, Vivian, Kersh, Ellen, Cavailler, Philippe, Mundade, Yamuna, Hal, Sebastiaan J van, Kundu, Ratan L, Hogan, Tiffany R, Whiley, David M, Izumi, Kiyohiko, Nishijima, Takeshi, EGASP Cambodia Working Group and Whiley, David (2024). High prevalence of ceftriaxone-resistant and XDR Neisseria gonorrhoeae in several cities of Cambodia, 2022–23: WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP). JAC-Antimicrobial Resistance, 6 (2) dlae053, 2. doi: 10.1093/jacamr/dlae053 |
|
2024 Journal Article Comparison of nasopharyngeal swab vs. lower respiratory tract specimen PCR for the diagnosis of Pneumocystis jirovecii pneumoniaChew, Rusheng, Tozer, Sarah, Ulett, Kimberly, Paterson, David L., Whiley, David, Sloots, Theo, Fielding, David, Zappala, Christopher, Bashirzadeh, Farzad, Hundloe, Justin, Bletchley, Cheryl and Woods, Marion L. (2024). Comparison of nasopharyngeal swab vs. lower respiratory tract specimen PCR for the diagnosis of Pneumocystis jirovecii pneumonia. Open Forum Infectious Diseases, 11 (3) ofae071, ofae071. doi: 10.1093/ofid/ofae071 |
|
2024 Journal Article Concurrent parC and gyrA fluoroquinolone resistance mutations and associated strains in Mycoplasma genitalium in Queensland, AustraliaErtl, Nicole G., Anderson, Taylah K., Pardo, Carolyn J., Maidment, Toby I., Murray, Gerald L., Bradshaw, Catriona S., Whiley, David M. and Sweeney, Emma L. (2024). Concurrent parC and gyrA fluoroquinolone resistance mutations and associated strains in Mycoplasma genitalium in Queensland, Australia. Journal of Antimicrobial Chemotherapy, 79 (2), 467-469. doi: 10.1093/jac/dkad373 |
|
2024 Journal Article Investigating oral human papillomavirus co-infection with Neisseria gonorrhoeae and Chlamydia trachomatisTrembizki, Ella, Anderson, Taylah, Whiley, David M. and Antonsson, Annika (2024). Investigating oral human papillomavirus co-infection with Neisseria gonorrhoeae and Chlamydia trachomatis. Epidemiology and Infection, 152 e8, e8. doi: 10.1017/s095026882300198x |
|
2024 Conference Publication Simplifying approaches to detect Mycoplasma genitalium parC resistance mutations, to facilitate individualised fluoroquinolone treatmentSweeney, Emma L., Bradshaw, Catriona, Murray, Gerald, Tickner, Jacob A. and Whiley, David (2024). Simplifying approaches to detect Mycoplasma genitalium parC resistance mutations, to facilitate individualised fluoroquinolone treatment. Annual Meeting of the Infectious-Diseases-Society-for-Obstetrics-and-Gynecology (IDSOG), Boston, MA, United States, 4-6 August 2022. Philadelphia, PA, United States: Lippincott Williams & Wilkins. |
|
2024 Conference Publication gyrA Mutations in Mycoplasma Genitalium Contribute to Moxifloxacin Failure - A New Target For Resistance-guided TherapyMurray, Gerald, Plummer, Erica L., Bodihabadu, Kaveesha, Torres, Jose, Chua, Teck-Phui, Machalek, Dorothy, Garland, Suzanne M., Doyle, Michelle, Sweeney, Emma L., Whiley, David and Bradshaw, Catriona (2024). gyrA Mutations in Mycoplasma Genitalium Contribute to Moxifloxacin Failure - A New Target For Resistance-guided Therapy. Annual Meeting of the Infectious-Diseases-Society-for-Obstetrics-and-Gynecology (IDSOG), Boston, MA, United States, 4-6 August 2022. Philadelphia, PA, United States: Lippincott Williams & Wilkins. |
